Pages that link to "Q37704975"
Jump to navigation
Jump to search
The following pages link to Broadly neutralizing antibodies against influenza viruses (Q37704975):
Displaying 50 items.
- The role of Fc-FcγR interactions in IgG-mediated microbial neutralization (Q26797466) (← links)
- Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico (Q30145646) (← links)
- Passive broad-spectrum influenza immunoprophylaxis (Q30367936) (← links)
- Broadly neutralizing anti-influenza virus antibodies: enhancement of neutralizing potency in polyclonal mixtures and IgA backbones. (Q30370793) (← links)
- A potent broad-spectrum protective human monoclonal antibody crosslinking two haemagglutinin monomers of influenza A virus (Q30377012) (← links)
- An Intranasal Virus-Like Particle Vaccine Broadly Protects Mice from Multiple Subtypes of Influenza A Virus. (Q30377023) (← links)
- Changes in heterosubtypic antibody responses during the first year of the 2009 A(H1N1) influenza pandemic (Q30384225) (← links)
- Priming Vaccination With Influenza Virus H5 Hemagglutinin Antigen Significantly Increases the Duration of T cell Responses Induced by a Heterologous H5 Booster Vaccination (Q30390832) (← links)
- Determination of antigenicity-altering patches on the major surface protein of human influenza A/H3N2 viruses (Q30394447) (← links)
- Adapting global influenza management strategies to address emerging viruses (Q30431093) (← links)
- Human antibody 3E1 targets the HA stem region of H1N1 and H5N6 influenza A viruses. (Q33815658) (← links)
- Inhibition of highly pathogenic avian influenza (HPAI) virus by a peptide derived from vFLIP through its direct destabilization of viruses (Q33884759) (← links)
- Virus-vectored influenza virus vaccines (Q34102268) (← links)
- Glycan masking of hemagglutinin for adenovirus vector and recombinant protein immunizations elicits broadly neutralizing antibodies against H5N1 avian influenza viruses (Q35132253) (← links)
- 3-O-galloylated procyanidins from Rumex acetosa L. inhibit the attachment of influenza A virus (Q35321520) (← links)
- A novel humanized antibody neutralizes H5N1 influenza virus via two different mechanisms (Q35488279) (← links)
- Vaccine-elicited antibody that neutralizes H5N1 influenza and variants binds the receptor site and polymorphic sites (Q35910153) (← links)
- Lamprey VLRB response to influenza virus supports universal rules of immunogenicity and antigenicity (Q36003473) (← links)
- Adaptive Heterosubtypic Immunity to Low Pathogenic Avian Influenza Viruses in Experimentally Infected Mallards (Q36255524) (← links)
- Broadly reactive aptamers targeting bacteria belonging to different genera using a sequential toggle cell-SELEX (Q36300521) (← links)
- High Antibody-Dependent Cellular Cytotoxicity Antibody Titers to H5N1 and H7N9 Avian Influenza A Viruses in Healthy US Adults and Older Children (Q36344790) (← links)
- Cross-reactivity between avian influenza A (H7N9) virus and divergent H7 subtypic- and heterosubtypic influenza A viruses (Q36611283) (← links)
- Discovery of Highly Potent Inhibitors Targeting the Predominant Drug-Resistant S31N Mutant of the Influenza A Virus M2 Proton Channel (Q36791678) (← links)
- Cross-reactive human B cell and T cell epitopes between influenza A and B viruses (Q37053710) (← links)
- Unmasking Stem-Specific Neutralizing Epitopes by Abolishing N-Linked Glycosylation Sites of Influenza Virus Hemagglutinin Proteins for Vaccine Design (Q37252942) (← links)
- A Broadly Reactive Human Anti-hemagglutinin Stem Monoclonal Antibody That Inhibits Influenza A Virus Particle Release (Q37714300) (← links)
- Influenza reverse genetics: dissecting immunity and pathogenesis (Q38188084) (← links)
- Development and applications of single-cycle infectious influenza A virus (sciIAV). (Q38556537) (← links)
- The role of structural proteomics in vaccine development: recent advances and future prospects (Q38682335) (← links)
- Structural Insights into Reovirus σ1 Interactions with Two Neutralizing Antibodies. (Q38727221) (← links)
- Antibody immunoprophylaxis and immunotherapy for influenza virus infection: utilization of monoclonal or polyclonal antibodies? (Q40065071) (← links)
- Extracellular Matrix Proteins Mediate HIV-1 gp120 Interactions with α4β7. (Q40080908) (← links)
- Heterosubtypic cross-reactivity of HA1 antibodies to influenza A, with emphasis on nonhuman subtypes (H5N1, H7N7, H9N2). (Q40120056) (← links)
- The Hemagglutinin A Stem Antibody MEDI8852 Prevents and Controls Disease and Limits Transmission of Pandemic Influenza Viruses (Q40152557) (← links)
- The bulky and the sweet: How neutralizing antibodies and glycan receptors compete for virus binding (Q41922286) (← links)
- Antibody 27F3 Broadly Targets Influenza A Group 1 and 2 Hemagglutinins through a Further Variation in VH1-69 Antibody Orientation on the HA Stem (Q41933744) (← links)
- Generation of monoclonal antibodies reactive against subtype specific conserved B-cell epitopes on haemagglutinin protein of influenza virus H5N1. (Q42174664) (← links)
- Progress toward the development of universal influenza vaccines. (Q42189566) (← links)
- Age and different influenza viruses (Q42753727) (← links)
- Structural insight into a human neutralizing antibody against influenza virus H7N9. (Q45323700) (← links)
- Immune responses in influenza A virus and human coronavirus infections: an ongoing battle between the virus and host (Q45324307) (← links)
- High throughput discovery of influenza virus neutralizing antibodies from phage-displayed synthetic antibody libraries (Q45325444) (← links)
- Sweep Dynamics (SD) plots: Computational identification of selective sweeps to monitor the adaptation of influenza A viruses (Q47555729) (← links)
- Genetic and subunit vaccines based on the stem domain of the equine influenza hemagglutinin provide homosubtypic protection against heterologous strains (Q49898952) (← links)
- Porcine reproductive and respiratory syndrome virus neutralizing antibodies provide in vivo cross-protection to PRRSV1 and PRRSV2 viral challenge (Q50166841) (← links)
- A Highly Potent and Broadly Neutralizing H1 Influenza-Specific Human Monoclonal Antibody. (Q52659466) (← links)
- Development of a high-throughput assay to detect antibody inhibition of low pH induced conformational changes of influenza virus hemagglutinin. (Q55501368) (← links)
- Deep mutational scanning of hemagglutinin helps predict evolutionary fates of human H3N2 influenza variants (Q56888351) (← links)
- Porous Nanoparticles With Self-Adjuvanting M2e-Fusion Protein and Recombinant Hemagglutinin Provide Strong and Broadly Protective Immunity Against Influenza Virus Infections (Q57091953) (← links)
- Mutations in influenza A virus neuraminidase and hemagglutinin confer resistance against a broadly neutralizing hemagglutinin stem antibody (Q58089563) (← links)